After finishing at $0.51 in the prior trading day, Origin Materials Inc (NASDAQ: ORGN) closed at $0.50, down -2.55%. In other words, the price has decreased by -$0.0131 from its previous closing price. On the day, 1207172 shares were traded.
Ratios:
Our goal is to gain a better understanding of ORGN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.45 and its Current Ratio is at 12.50. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On October 14, 2022, Credit Suisse started tracking the stock assigning a Outperform rating and target price of $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 13 when Bissell John sold 40,000 shares for $0.78 per share. The transaction valued at 31,224 led to the insider holds 1,173,828 shares of the business.
Lee Joshua C. sold 17,500 shares of ORGN for $13,556 on Dec 13. The General Counsel now owns 261,194 shares after completing the transaction at $0.77 per share. On Nov 13, another insider, Lee Joshua C., who serves as the General Counsel of the company, sold 12,400 shares for $0.92 each. As a result, the insider received 11,353 and left with 278,694 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGN now has a Market Capitalization of 72.14M and an Enterprise Value of -109.26M. As of this moment, Origin’s Price-to-Earnings (P/E) ratio for their current fiscal year is 1.43. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.58 while its Price-to-Book (P/B) ratio in mrq is 0.17. Its current Enterprise Value per Revenue stands at -6.94 whereas that against EBITDA is -1.61.
Stock Price History:
Over the past 52 weeks, ORGN has reached a high of $5.19, while it has fallen to a 52-week low of $0.48. The 50-Day Moving Average of the stock is 0.6722, while the 200-Day Moving Average is calculated to be 2.0666.
Shares Statistics:
The stock has traded on average 1.60M shares per day over the past 3-months and 1.57M shares per day over the last 10 days, according to various share statistics. A total of 143.03M shares are outstanding, with a floating share count of 109.95M. Insiders hold about 23.80% of the company’s shares, while institutions hold 23.48% stake in the company. Shares short for ORGN as of Jan 31, 2024 were 6.43M with a Short Ratio of 4.01, compared to 5.07M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 4.46% and a Short% of Float of 6.26%.
Earnings Estimates
Its stock is currently analyzed by 1 different market analysts. On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.14, while EPS last year was $0.11. The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.15 and low estimates of -$0.15.
Analysts are recommending an EPS of between $0.1 and $0.1 for the fiscal current year, implying an average EPS of $0.1. EPS for the following year is -$0.61, with 1 analysts recommending between -$0.61 and -$0.61.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $122M in the next fiscal year. The high estimate is $122M and the low estimate is $122M. The average revenue growth estimate for next year is up 335.70% from the average revenue estimate for this year.
